Plasma Therapy Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Plasma Therapy Market to 2027 - Global Analysis and Forecasts by Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin); Source (Autologous, Allogenic); Application (Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury, Others); End User (Hospitals and Clinics, Research Institutes) and Geography

Report Code: TIPRE00004429 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Plasma therapy is one of the conventional techniques that is majorly used in orthopedic, dentistry and dermatologic specialties. Plasma therapy finds its extensive applications in wound healing, face rejuvenation and androgenetic alopecia. Healing is facilitated when high concentrated plasma, up to 3-5 times of its physiologic value is injected into the patients' tissues.

MARKET DYNAMICS
The plasma therapy market is anticipated to grow in the forecast, owing to rising geriatric population, and increasing demand for minimally invasive therapies. In addition, rising number of patients suffering from orthopedic disorders and androgenic alopecia is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE
The "Global Plasma Therapy Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of plasma therapy market with detailed market segmentation by type, source, application, end user, and geography. The global plasma therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading plasma therapy market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global plasma therapy market is segmented on the basis of by type, source, application, and end user. Based on type, the market is segmented as, pure PRP, leukocyte-rich PRP, pure platelet-rich fibrin, leukocyte-rich fibrin. Based on source, the market is segmented in to autologous, and allogenic. On the basis of application, the plasma therapy market is categorized as per orthopedic, dermatology, cardiac muscle injury, dental, nerve injury, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global plasma therapy market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The plasma therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting plasma therapy market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the plasma therapy market in these regions.

MARKET PLAYERS
The reports cover key developments in the plasma therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from plasma therapy market are anticipated to lucrative growth opportunities in the future with the rising demand for plasma therapy market in the global market. Below mentioned is the list of few companies engaged in the plasma therapy market.

The report also includes the profiles of key plasma therapy market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Terumo BCT, Inc
  • Biolife Plasma Services
  • The LFB Group
  • Cambryn Biologics
  • CSL Limited
  • Kedrion S.p.A
  • Grifols, S.A.
  • Bio Products Laboratory Ltd.
  • China Biologic Products Holdings, Inc.
  • Octapharma
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Plasma Therapy Market - By Type
1.3.2 Plasma Therapy Market - By Source
1.3.3 Plasma Therapy Market - By Application
1.3.4 Plasma Therapy Market - By End User
1.3.5 Plasma Therapy Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. PLASMA THERAPY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PLASMA THERAPY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PLASMA THERAPY MARKET - GLOBAL MARKET ANALYSIS
6.1. PLASMA THERAPY - GLOBAL MARKET OVERVIEW
6.2. PLASMA THERAPY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PLASMA THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PURE PRP
7.3.1. Overview
7.3.2. Pure PRP Market Forecast and Analysis
7.4. LEUKOCYTE-RICH PRP
7.4.1. Overview
7.4.2. Leukocyte-Rich PRP Market Forecast and Analysis
7.5. PURE PLATELET-RICH FIBRIN
7.5.1. Overview
7.5.2. Pure Platelet-Rich Fibrin Market Forecast and Analysis
7.6. LEUKOCYTE-RICH FIBRIN
7.6.1. Overview
7.6.2. Leukocyte-Rich Fibrin Market Forecast and Analysis
8. PLASMA THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - SOURCE
8.1. OVERVIEW
8.2. SOURCE MARKET FORECASTS AND ANALYSIS
8.3. AUTOLOGOUS
8.3.1. Overview
8.3.2. Autologous Market Forecast and Analysis
8.4. ALLOGENIC
8.4.1. Overview
8.4.2. Allogenic Market Forecast and Analysis
9. PLASMA THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. ORTHOPEDIC
9.3.1. Overview
9.3.2. Orthopedic Market Forecast and Analysis
9.4. DERMATOLOGY
9.4.1. Overview
9.4.2. Dermatology Market Forecast and Analysis
9.5. CARDIAC MUSCLE INJURY
9.5.1. Overview
9.5.2. Cardiac Muscle Injury Market Forecast and Analysis
9.6. DENTAL
9.6.1. Overview
9.6.2. Dental Market Forecast and Analysis
9.7. NERVE INJURY
9.7.1. Overview
9.7.2. Nerve Injury Market Forecast and Analysis
9.8. OTHERS
9.8.1. Overview
9.8.2. Others Market Forecast and Analysis
10. PLASMA THERAPY MARKET - REVENUE AND FORECASTS TO 2027 - END USER
10.1. OVERVIEW
10.2. END USER MARKET FORECASTS AND ANALYSIS
10.3. HOSPITALS AND CLINICS
10.3.1. Overview
10.3.2. Hospitals and Clinics Market Forecast and Analysis
10.4. RESEARCH INSTITUTES
10.4.1. Overview
10.4.2. Research Institutes Market Forecast and Analysis
11. PLASMA THERAPY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Plasma Therapy Market Overview
11.1.2 North America Plasma Therapy Market Forecasts and Analysis
11.1.3 North America Plasma Therapy Market Forecasts and Analysis - By Type
11.1.4 North America Plasma Therapy Market Forecasts and Analysis - By Source
11.1.5 North America Plasma Therapy Market Forecasts and Analysis - By Application
11.1.6 North America Plasma Therapy Market Forecasts and Analysis - By End User
11.1.7 North America Plasma Therapy Market Forecasts and Analysis - By Countries
11.1.7.1 United States Plasma Therapy Market
11.1.7.1.1 United States Plasma Therapy Market by Type
11.1.7.1.2 United States Plasma Therapy Market by Source
11.1.7.1.3 United States Plasma Therapy Market by Application
11.1.7.1.4 United States Plasma Therapy Market by End User
11.1.7.2 Canada Plasma Therapy Market
11.1.7.2.1 Canada Plasma Therapy Market by Type
11.1.7.2.2 Canada Plasma Therapy Market by Source
11.1.7.2.3 Canada Plasma Therapy Market by Application
11.1.7.2.4 Canada Plasma Therapy Market by End User
11.1.7.3 Mexico Plasma Therapy Market
11.1.7.3.1 Mexico Plasma Therapy Market by Type
11.1.7.3.2 Mexico Plasma Therapy Market by Source
11.1.7.3.3 Mexico Plasma Therapy Market by Application
11.1.7.3.4 Mexico Plasma Therapy Market by End User
11.2. EUROPE
11.2.1 Europe Plasma Therapy Market Overview
11.2.2 Europe Plasma Therapy Market Forecasts and Analysis
11.2.3 Europe Plasma Therapy Market Forecasts and Analysis - By Type
11.2.4 Europe Plasma Therapy Market Forecasts and Analysis - By Source
11.2.5 Europe Plasma Therapy Market Forecasts and Analysis - By Application
11.2.6 Europe Plasma Therapy Market Forecasts and Analysis - By End User
11.2.7 Europe Plasma Therapy Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Plasma Therapy Market
11.2.7.1.1 Germany Plasma Therapy Market by Type
11.2.7.1.2 Germany Plasma Therapy Market by Source
11.2.7.1.3 Germany Plasma Therapy Market by Application
11.2.7.1.4 Germany Plasma Therapy Market by End User
11.2.7.2 France Plasma Therapy Market
11.2.7.2.1 France Plasma Therapy Market by Type
11.2.7.2.2 France Plasma Therapy Market by Source
11.2.7.2.3 France Plasma Therapy Market by Application
11.2.7.2.4 France Plasma Therapy Market by End User
11.2.7.3 Italy Plasma Therapy Market
11.2.7.3.1 Italy Plasma Therapy Market by Type
11.2.7.3.2 Italy Plasma Therapy Market by Source
11.2.7.3.3 Italy Plasma Therapy Market by Application
11.2.7.3.4 Italy Plasma Therapy Market by End User
11.2.7.4 Spain Plasma Therapy Market
11.2.7.4.1 Spain Plasma Therapy Market by Type
11.2.7.4.2 Spain Plasma Therapy Market by Source
11.2.7.4.3 Spain Plasma Therapy Market by Application
11.2.7.4.4 Spain Plasma Therapy Market by End User
11.2.7.5 United Kingdom Plasma Therapy Market
11.2.7.5.1 United Kingdom Plasma Therapy Market by Type
11.2.7.5.2 United Kingdom Plasma Therapy Market by Source
11.2.7.5.3 United Kingdom Plasma Therapy Market by Application
11.2.7.5.4 United Kingdom Plasma Therapy Market by End User
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Plasma Therapy Market Overview
11.3.2 Asia-Pacific Plasma Therapy Market Forecasts and Analysis
11.3.3 Asia-Pacific Plasma Therapy Market Forecasts and Analysis - By Type
11.3.4 Asia-Pacific Plasma Therapy Market Forecasts and Analysis - By Source
11.3.5 Asia-Pacific Plasma Therapy Market Forecasts and Analysis - By Application
11.3.6 Asia-Pacific Plasma Therapy Market Forecasts and Analysis - By End User
11.3.7 Asia-Pacific Plasma Therapy Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Plasma Therapy Market
11.3.7.1.1 Australia Plasma Therapy Market by Type
11.3.7.1.2 Australia Plasma Therapy Market by Source
11.3.7.1.3 Australia Plasma Therapy Market by Application
11.3.7.1.4 Australia Plasma Therapy Market by End User
11.3.7.2 China Plasma Therapy Market
11.3.7.2.1 China Plasma Therapy Market by Type
11.3.7.2.2 China Plasma Therapy Market by Source
11.3.7.2.3 China Plasma Therapy Market by Application
11.3.7.2.4 China Plasma Therapy Market by End User
11.3.7.3 India Plasma Therapy Market
11.3.7.3.1 India Plasma Therapy Market by Type
11.3.7.3.2 India Plasma Therapy Market by Source
11.3.7.3.3 India Plasma Therapy Market by Application
11.3.7.3.4 India Plasma Therapy Market by End User
11.3.7.4 Japan Plasma Therapy Market
11.3.7.4.1 Japan Plasma Therapy Market by Type
11.3.7.4.2 Japan Plasma Therapy Market by Source
11.3.7.4.3 Japan Plasma Therapy Market by Application
11.3.7.4.4 Japan Plasma Therapy Market by End User
11.3.7.5 South Korea Plasma Therapy Market
11.3.7.5.1 South Korea Plasma Therapy Market by Type
11.3.7.5.2 South Korea Plasma Therapy Market by Source
11.3.7.5.3 South Korea Plasma Therapy Market by Application
11.3.7.5.4 South Korea Plasma Therapy Market by End User
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Plasma Therapy Market Overview
11.4.2 Middle East and Africa Plasma Therapy Market Forecasts and Analysis
11.4.3 Middle East and Africa Plasma Therapy Market Forecasts and Analysis - By Type
11.4.4 Middle East and Africa Plasma Therapy Market Forecasts and Analysis - By Source
11.4.5 Middle East and Africa Plasma Therapy Market Forecasts and Analysis - By Application
11.4.6 Middle East and Africa Plasma Therapy Market Forecasts and Analysis - By End User
11.4.7 Middle East and Africa Plasma Therapy Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Plasma Therapy Market
11.4.7.1.1 South Africa Plasma Therapy Market by Type
11.4.7.1.2 South Africa Plasma Therapy Market by Source
11.4.7.1.3 South Africa Plasma Therapy Market by Application
11.4.7.1.4 South Africa Plasma Therapy Market by End User
11.4.7.2 Saudi Arabia Plasma Therapy Market
11.4.7.2.1 Saudi Arabia Plasma Therapy Market by Type
11.4.7.2.2 Saudi Arabia Plasma Therapy Market by Source
11.4.7.2.3 Saudi Arabia Plasma Therapy Market by Application
11.4.7.2.4 Saudi Arabia Plasma Therapy Market by End User
11.4.7.3 U.A.E Plasma Therapy Market
11.4.7.3.1 U.A.E Plasma Therapy Market by Type
11.4.7.3.2 U.A.E Plasma Therapy Market by Source
11.4.7.3.3 U.A.E Plasma Therapy Market by Application
11.4.7.3.4 U.A.E Plasma Therapy Market by End User
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Plasma Therapy Market Overview
11.5.2 South and Central America Plasma Therapy Market Forecasts and Analysis
11.5.3 South and Central America Plasma Therapy Market Forecasts and Analysis - By Type
11.5.4 South and Central America Plasma Therapy Market Forecasts and Analysis - By Source
11.5.5 South and Central America Plasma Therapy Market Forecasts and Analysis - By Application
11.5.6 South and Central America Plasma Therapy Market Forecasts and Analysis - By End User
11.5.7 South and Central America Plasma Therapy Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Plasma Therapy Market
11.5.7.1.1 Brazil Plasma Therapy Market by Type
11.5.7.1.2 Brazil Plasma Therapy Market by Source
11.5.7.1.3 Brazil Plasma Therapy Market by Application
11.5.7.1.4 Brazil Plasma Therapy Market by End User
11.5.7.2 Argentina Plasma Therapy Market
11.5.7.2.1 Argentina Plasma Therapy Market by Type
11.5.7.2.2 Argentina Plasma Therapy Market by Source
11.5.7.2.3 Argentina Plasma Therapy Market by Application
11.5.7.2.4 Argentina Plasma Therapy Market by End User
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PLASMA THERAPY MARKET, KEY COMPANY PROFILES
13.1. TERUMO BCT, INC
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BIOLIFE PLASMA SERVICES
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. THE LFB GROUP
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CAMBRYN BIOLOGICS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. CSL LIMITED
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. KEDRION S.P.A
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. GRIFOLS, S.A.
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BIO PRODUCTS LABORATORY LTD.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. OCTAPHARMA
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Terumo BCT, Inc
2. Biolife Plasma Services
3. The LFB Group
4. Cambryn Biologics
5. CSL Limited
6. Kedrion S. p. A
7. Grifols, S. A.
8. Bio Products Laboratory Ltd.
9. China Biologic Products Holdings, Inc.
10. Octapharma
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book